f Volatilome: A Novel Tool for Risk Scoring in Ischemic Heart Disease

References

1. TsaoC.W. AdayA.W. AlmarzooqZ.I. Heart Disease and Stroke Statistics—2023 Update: A report From the American Heart Association.Circulation20231478e93e62110.1161/CIR.0000000000001123 36695182
   [Google Scholar]
2. DorresteijnJ.A.N. VisserenF.L.J. WassinkA.M.J. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: The SMART risk score.Heart2013991286687210.1136/heartjnl‑2013‑303640 23574971
   [Google Scholar]
3. VisserenF.L.J. MachF. SmuldersY.M. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.Eur. Heart J.202142343227333710.1093/eurheartj/ehab484 34458905
   [Google Scholar]
4. de VriesT.I. CooneyM.T. SelmerR.M. SCORE2-OP risk prediction algorithms: Estimating incident cardiovascular event risk in older persons in four geographical risk regions.Eur. Heart J.202142252455246710.1093/eurheartj/ehab312 34120185
   [Google Scholar]
5. HagemanS. PennellsL. OjedaF. SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe.Eur. Heart J.202142252439245410.1093/eurheartj/ehab309 34120177
   [Google Scholar]
6. NurmohamedN.S. KraaijenhofJ.M. MayrM. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.Eur. Heart J.202344181594160710.1093/eurheartj/ehad161 36988179
   [Google Scholar]
7. MočnikM. Marčun VardaN. Lipid biomarkers and atherosclerosis—old and new in cardiovascular risk in childhood.Int. J. Mol. Sci.2023243223710.3390/ijms24032237 36768558
   [Google Scholar]
8. MarzoogB.A. Endothelial dysfunction under the scope of arterial hypertension, coronary heart disease, and diabetes mellitus using the angioscan.Cardiovasc. Hematol. Agents Med. Chem.202422218118610.2174/0118715257246589231018053646 37921186
   [Google Scholar]
9. MarzoogB.A. VlasovaT.I. Membrane lipids under norm and pathology.European J Clin Exp Med2021191597510.15584/ejcem.2021.1.9
   [Google Scholar]
10. MarzoogB.A. Tree of life: Endothelial cell in norm and disease, the good guy is a partner in crime!Anat. Cell Biol.202356216617810.5115/acb.22.190 36879408
    [Google Scholar]
11. ZhuD. VernonS.T. D’AgostinoZ. Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort.Biomolecules202313691710.3390/biom13060917 37371497
    [Google Scholar]
12. DuganiS.B. MoorthyM.V. LiC. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women.JAMA Cardiol.20216443744710.1001/jamacardio.2020.7073 33471027
    [Google Scholar]
13. MarzoogB.A. Recent advances in molecular biology of metabolic syndrome pathophysiology: Endothelial dysfunction as a potential therapeutic target.J. Diabetes Metab. Disord.20222121903191110.1007/s40200‑022‑01088‑y 36065330
    [Google Scholar]
14. MarzoogB.A. Endothelial cell autophagy in the context of disease development.Anat. Cell Biol.2023561162410.5115/acb.22.098 36267005
    [Google Scholar]
15. MarzoogB. Breathomics detect the cardiovascular disease: Delusion or dilution of the metabolomic signature.Curr. Cardiol. Rev.2024204e02022422664710.2174/011573403X283768240124065853 38318837
    [Google Scholar]
16. Abdullah MarzoogB. Caveolae’s behavior in norm and pathology.Emir. Med. J.202342e08052321663910.2174/0250688204666230508112229
    [Google Scholar]
17. MarzoogB.A. The metabolic syndrome puzzles; possible pathogenesis and management.Curr. Diabetes Rev.2023194e29042220425810.2174/1573399818666220429100411 35507784
    [Google Scholar]
18. KistJ.M. VosR.C. MairuhuA.T.A. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: An external validation study.EClinMed20235710186210.1016/j.eclinm.2023.101862 36864978
    [Google Scholar]
19. BrunströmM. AnderssonJ. EliassonM. FuM. HanssonP-O. SöderbergS. SCORE2 - an updated model for cardiovascular risk predictionLakartidningen20212021118
    [Google Scholar]
20. YariA UedaP HagstromE Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals. . Eur Heart J202243Suppl. 2ehac544.227910.1093/eurheartj/ehac544.2279
    [Google Scholar]
21. MarzoogB.A. AbdullaevM. SuvorovA. Single channel electrocardiography optimizes the diagnostic accuracy of bicycle ergometry!medRxiv202410.1101/2024.04.20.24306122
    [Google Scholar]
22. KasimSS IbrahimN MalekS Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population. Lancet Reg Health - Western Pac 20233510074210.1016/j.lanwpc.2023.10074237424687
    [Google Scholar]